Oncternal Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2013 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Oncternal Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2013 to 2023.
  • Oncternal Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -2.86 USD/shares, a 14.6% increase year-over-year.
  • Oncternal Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -11.7 USD/shares, a 55.9% increase year-over-year.
  • Oncternal Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -13.4 USD/shares, a 20.1% increase from 2022.
  • Oncternal Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -16.8 USD/shares, a 2525% decline from 2021.
  • Oncternal Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -0.64 USD/shares.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$13 +$3.37 +20.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 -$17 -$16 -2525% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 -$1 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2017 -$2 -$1 -43.4% Jan 1, 2017 Dec 31, 2017 10-K 2018-03-13
2016 -$1 +$0.11 +8.27% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-13
2015 -$1 +$3.49 +72.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-13
2014 -$5 -$4 -619% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-24
2013 -$1 Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.